Peters Malte 4
4 · HOOKIPA Pharma Inc. · Filed Jul 23, 2025
Insider Transaction Report
Form 4
Peters Malte
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-07-22$0.92/sh−29,176$26,842→ 79,519 total
Footnotes (1)
- [F1]This sale was affected pursuant to a "sell to cover" arrangement adopted by the Issuer to satisfy the tax withholding obligations triggered by the vesting of restricted stock units granted on July 22, 2024 and does not represent a discretionary trade by the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.